These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7677904)

  • 1. Hepatitis C infection from anti-D immunoglobulin.
    Power JP; Davidson F; O'Riordan J; Simmonds P; Yap PL; Lawlor E
    Lancet; 1995 Aug; 346(8971):372-3. PubMed ID: 7677904
    [No Abstract]   [Full Text] [Related]  

  • 2. A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland.
    Smith DB; Lawlor E; Power J; O'Riordan J; McAllister J; Lycett C; Davidson F; Pathirana S; Garson JA; Tedder RS; Yap PL; Simmonds P
    Vox Sang; 1999; 76(3):175-80. PubMed ID: 10341334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
    Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
    Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin.
    Power JP; Lawlor E; Davidson F; Yap PL; Kenny-Walsh E; Whelton MJ; Walsh TJ
    Lancet; 1994 Oct; 344(8930):1166-7. PubMed ID: 7934528
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C infection from anti-D immunoglobulin.
    Foster PR; McIntosh RV; Welch AG
    Lancet; 1995 Aug; 346(8971):372. PubMed ID: 7623543
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.
    Lawlor E; Columb G
    N Engl J Med; 1999 Sep; 341(10):762; author reply 763. PubMed ID: 10475797
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus and intravenous anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1995 Jun; 5(24):111, 114. PubMed ID: 7542122
    [No Abstract]   [Full Text] [Related]  

  • 8. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
    Yap PL
    Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ireland announces compensation for hepatitis c.
    Wilson-Davis K
    BMJ; 1995 Sep; 311(7008):771. PubMed ID: 7580436
    [No Abstract]   [Full Text] [Related]  

  • 10. A likelihood-based method of identifying contaminated lots of blood product.
    Reilly M; Lawlor E
    Int J Epidemiol; 1999 Aug; 28(4):787-92. PubMed ID: 10480712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C transmission -- where are we now?
    Clarke A; Kulasegaram R
    Int J STD AIDS; 2006 Feb; 17(2):74-80; quiz 80. PubMed ID: 16464265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus associated with Irish anti-D immunoglobulin.
    Commun Dis Rep CDR Wkly; 1994 Mar; 4(9):39. PubMed ID: 7513236
    [No Abstract]   [Full Text] [Related]  

  • 13. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts.
    Sachithanandan S; Fielding JF
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for hepatitis C: past, present and future.
    Delwaide J; Bourgeois N; Colle I; Robaeys G
    Acta Gastroenterol Belg; 2002; 65(2):87-9. PubMed ID: 12148445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctors to face disciplinary action over Irish hepatitis C scandal.
    Payne D
    BMJ; 1998 Jan; 316(7125):93. PubMed ID: 9462311
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.
    Kenny-Walsh E
    N Engl J Med; 1999 Apr; 340(16):1228-33. PubMed ID: 10210705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrafamilial transmission of hepatitis C virus: infection of the father predicts the risk of perinatal transmission.
    Indolfi G; Bartolini E; Azzari C; Becciolini L; Moriondo M; de Martino M; Resti M
    J Med Virol; 2008 Nov; 80(11):1907-11. PubMed ID: 18814243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study.
    Fanning L; Kenny-Walsh E; Levis J; Choudhury KR; Cannon B; Sheehan M; Whelton M; Shanahan F
    Hepatology; 2000 Jan; 31(1):225-9. PubMed ID: 10613750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.
    Bonis PA
    N Engl J Med; 1999 Sep; 341(10):763. PubMed ID: 10475798
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vertical transmission of hepatitis C virus].
    Rubio Quevedo C; Holgado Carballo MA; García Suárez A; Martín de Lara IM; Moltó Ripoll L
    An Esp Pediatr; 2001 Jan; 54(1):27-31. PubMed ID: 11181191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.